Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 2
2018 6
2019 9
2020 12
2021 9
2022 10
2023 7
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Among authors: perugino ca. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Stone JH, et al. Among authors: perugino ca. N Engl J Med. 2025 Mar 27;392(12):1168-1177. doi: 10.1056/NEJMoa2409712. Epub 2024 Nov 14. N Engl J Med. 2025. PMID: 39541094 Clinical Trial.
Proliferative features of IgG4-related disease.
Katz G, Hernandez-Barco Y, Palumbo D, Guy TV, Dong L, Perugino CA. Katz G, et al. Among authors: perugino ca. Lancet Rheumatol. 2024 Jul;6(7):e481-e492. doi: 10.1016/S2665-9913(24)00022-5. Epub 2024 Apr 1. Lancet Rheumatol. 2024. PMID: 38574744 Review.
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Wallace ZS, et al. Among authors: perugino ca. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. Ann Rheum Dis. 2020. PMID: 31796497 Review.
Reply.
Perugino CA, Liu H, Pillai S. Perugino CA, et al. Arthritis Rheumatol. 2020 Sep;72(9):1585-1586. doi: 10.1002/art.41389. Epub 2020 Jul 20. Arthritis Rheumatol. 2020. PMID: 32524774 No abstract available.
Reply.
Perugino CA, Stone JH. Perugino CA, et al. Arthritis Rheumatol. 2018 Feb;70(2):318. doi: 10.1002/art.40362. Epub 2018 Jan 3. Arthritis Rheumatol. 2018. PMID: 29088581 No abstract available.
Immunoglobulin G4-related Disease.
Wallace ZS, Perugino C, Matza M, Deshpande V, Sharma A, Stone JH. Wallace ZS, et al. Among authors: perugino c. Clin Chest Med. 2019 Sep;40(3):583-597. doi: 10.1016/j.ccm.2019.05.005. Clin Chest Med. 2019. PMID: 31376893 Free PMC article. Review.
58 results